We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
+$29.7M
Cap. Flow %
0.25%
Top 10 Hldgs %
34.83%
Holding
1,447
New
32
Increased
612
Reduced
360
Closed
43

Sector Composition

Rank Sector Weight
1 Real Estate 59.18%
2 Technology 9.44%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
1101
Pacira BioSciences
PCRX
$1.04B
$9K ﹤0.01%
169
PRTA icon
1102
Prothena Corp
PRTA
$448M
$9K ﹤0.01%
154
RLAY icon
1103
Relay Therapeutics
RLAY
$4B
$9K ﹤0.01%
405
SAGE
1104
DELISTED
Sage Therapeutics
SAGE
$9K ﹤0.01%
220
ZLAB icon
1105
Zai Lab
ZLAB
$2.07B
$9K ﹤0.01%
255
RXDX
1106
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$9K ﹤0.01%
146
ACAD icon
1107
Acadia Pharmaceuticals
ACAD
$4.51B
$8K ﹤0.01%
469
FATE icon
1108
Fate Therapeutics
FATE
$275M
$8K ﹤0.01%
360
LEGN icon
1109
Legend Biotech
LEGN
$3.65B
$8K ﹤0.01%
199
SCHL icon
1110
Scholastic
SCHL
$774M
$8K ﹤0.01%
250
-700
-74% -$29.2K
VERV
1111
DELISTED
Verve Therapeutics
VERV
$8K ﹤0.01%
221
+80
+57% +$2.55K
ISEE
1112
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8K ﹤0.01%
434
BNS icon
1113
Scotiabank
BNS
$105B
$7K ﹤0.01%
150
-85
-36% -$4.86K
IBRX icon
1114
ImmunityBio
IBRX
$7.15B
$7K ﹤0.01%
1,483
-24,106
-94% -$110K
KRYS icon
1115
Krystal Biotech
KRYS
$10.7B
$7K ﹤0.01%
96
LYEL icon
1116
Lyell Immunopharma
LYEL
$318M
$7K ﹤0.01%
46
RXRX icon
1117
Recursion Pharmaceuticals
RXRX
$1.58B
$7K ﹤0.01%
611
-11,584
-95% -$117K
TWST icon
1118
Twist Bioscience
TWST
$5.32B
$7K ﹤0.01%
210
XENE icon
1119
Xenon Pharmaceuticals
XENE
$6.1B
$7K ﹤0.01%
198
RVNC
1120
DELISTED
Revance Therapeutics, Inc.
RVNC
$7K ﹤0.01%
246
AGIO icon
1121
Agios Pharmaceuticals
AGIO
$2.08B
$6K ﹤0.01%
204
ALLO icon
1122
Allogene Therapeutics
ALLO
$625M
$6K ﹤0.01%
535
AXSM icon
1123
Axsome Therapeutics
AXSM
$11.7B
$6K ﹤0.01%
129
IOVA icon
1124
Iovance Biotherapeutics
IOVA
$2.04B
$6K ﹤0.01%
586
IRWD icon
1125
Ironwood Pharmaceuticals
IRWD
$586M
$6K ﹤0.01%
573

Similar funds

Daiwa Securities Group's Q3 2022 Portfolio in Review

As of Q3 2022, Daiwa Securities Group held 1,447 positions worth $12B, down 8% from $13.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q3 2022 filing shows 32 new, 612 increased, 360 reduced and 43 closed positions. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M. The largest sale was Duke Realty Corp., an estimated $243M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q3 2022 buy was NextEra Energy, Inc. 5.279% Corporate Units: 150,000 shares worth $7.43M.
  • Daiwa Securities Group added most to First Industrial Realty Trust in Q3 2022, an estimated $172M increase.
  • Daiwa Securities Group's biggest Q3 2022 reduction was Duke Realty Corp., cutting an estimated $243M.
  • Daiwa Securities Group fully exited Chefs' Warehouse in Q3 2022, selling an estimated $2.69M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12B portfolio in Q3 2022.
  • Daiwa Securities Group opened 32 new positions and closed 43 in Q3 2022.
  • Daiwa Securities Group's portfolio value fell 8% quarter-over-quarter to $12B.

Based on Daiwa Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.